Home   中文简体 中文繁體 
Company News Products R&D Investor relationship Human Resource Contact Us
 
 
 
News
 
The Permission for Clinical Trial for Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection was issued   2017-02-01 10:35
“Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection” was approved to conduct clinical trial by CFDA on 23rd, January in 2017.
Links  |  SiteMap  |  Privacy Copyright© Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd. 2007
(沪)-非经营性-2015-0015    沪ICP备10027510号-1